Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.32M |
|
-- |
|
-- |
|
$3.49M |
|
$-3.49M |
|
$0.16M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.49M |
|
$-3.49M |
|
22.81M |
|
22.81M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$11.98M |
|
$0.24M |
|
$0.84M |
|
$12.82M |
|
$2.25M |
|
-- |
|
$0.18M |
|
$2.43M |
|
$10.39M |
|
$10.39M |
|
$10.39M |
|
18.86M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.97% |
|
-31.97% |
|
-25.92% |
|
-31.97% |
|
$0.55 |
|
-- |
|
-- |
|